Cargando…
Purpuric Drug Eruption in a Patient with Atopic Dermatitis Treated with Dupilumab
Autores principales: | WANG, Mingxia, ZHENG, Qi, TANG, Suwei, SHEN, Fang, JIANG, Wencheng |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Society for Publication of Acta Dermato-Venereologica
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9593475/ https://www.ncbi.nlm.nih.gov/pubmed/35670327 http://dx.doi.org/10.2340/actadv.v102.2245 |
Ejemplares similares
-
Immune Thrombocytopenic Purpura in a Patient with Atopic Dermatitis Treated with Dupilumab
por: FREY, Surina, et al.
Publicado: (2021) -
Transitory Dissemination of Molluscum Contagiosum in a Patient Treated with Dupilumab for Atopic Dermatitis
por: FERRUCCI, Silvia, et al.
Publicado: (2020) -
Long-term Remission of Atopic Dermatitis after Discontinuation of Dupilumab
por: MIYAMOTO, Shoko, et al.
Publicado: (2022) -
Dupilumab in the Treatment of Cheilitis in Atopic Dermatitis Patients
por: Shan, Jinpeng, et al.
Publicado: (2022) -
Successful Treatment of Atopic Dermatitis with Dupilumab in a Patient with Non-Hodgkin’s Lymphoma
por: QIU, YunMi, et al.
Publicado: (2022)